Sebi will act against pharma cos in case of non-disclosure of material information, says Tyagi

Mumbai: Markets regulator Sebi on Thursday said it would take action against pharma companies if they are found not sharing information on material events like inspections and reports by the US FDA.

“It is necessary to share material information even now. If the US FDA (Food and Drug Administration) has taken any action against them (pharmaceutical companies) and they are not disclosing it, if that comes before us, we will take action,” Sebi chairman Ajay Tyagi told reporters here.

He was replying to a specific question pertaining to pharma companies not disclosing actions by drug regulators in foreign markets like the US FDA undertaking inspections of their facilities and passing orders.

There have allegedly been instances of such happenings not being properly disclosed to the investors.

Tyagi said such information that constitutes to be “material information” should be shared with the stock exchanges immediately by the respective companies.

India is one of the world’s biggest pharma exporters and many of the domestic players in the sector are listed on the exchanges.

  • Related Posts

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    The Court observed that the alleged short supply of one tablet, coupled with the collection of ₹1.12, did not establish that the accused had sold the drug at a price…

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    MEERUT/SHIMLA: An illegal pharmaceutical factory allegedly manufacturing counterfeit medicines used to treat epilepsy, diabetes, typhoid and other ailments using substances such as chalk and lactose was busted in Himachal Pradesh’s…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    Karnataka High Court quashes case against MedPlus over short supply of one tablet costing ₹1.12

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    Fake epilepsy, diabetes drugs made using chalk, lactose at illegal Himachal factory; 2 held

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

    ‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

    ‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

    A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

    A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital